{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T15:16:01Z","timestamp":1723043761898},"reference-count":28,"publisher":"Japanese Society of Toxicologic Pathology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Toxicol Pathol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1293\/tox.2019-0040","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T22:04:02Z","timestamp":1576706642000},"page":"67-76","source":"Crossref","is-referenced-by-count":3,"title":["Tissue-specific effects of an anti-desmoglein-3 ADCC antibody due to          expression of the target antigen and physiological characteristics of the mouse          vagina"],"prefix":"10.1293","volume":"33","author":[{"given":"Etsuko","family":"Fujii","sequence":"first","affiliation":[{"name":"Forerunner Pharma Research Co., Ltd., Komaba Open              Laboratory, The University of Tokyo, 6-1 Komaba 4, Meguro, Tokyo 153-8904,              Japan"},{"name":"Chugai Pharmaceutical Co., Ltd., 1-135 Komakado,              Gotemba, Shizuoka 412-8513, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Funahashi","sequence":"additional","affiliation":[{"name":"Forerunner Pharma Research Co., Ltd., Komaba Open              Laboratory, The University of Tokyo, 6-1 Komaba 4, Meguro, Tokyo 153-8904,              Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Chugai Pharmaceutical Co., Ltd., 1-135 Komakado,              Gotemba, Shizuoka 412-8513, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeto","family":"Kawai","sequence":"additional","affiliation":[{"name":"Forerunner Pharma Research Co., Ltd., Komaba Open              Laboratory, The University of Tokyo, 6-1 Komaba 4, Meguro, Tokyo 153-8904,              Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyotaka","family":"Nakano","sequence":"additional","affiliation":[{"name":"Forerunner Pharma Research Co., Ltd., Komaba Open              Laboratory, The University of Tokyo, 6-1 Komaba 4, Meguro, Tokyo 153-8904,              Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiko","family":"Kato","sequence":"additional","affiliation":[{"name":"Chugai Pharmaceutical Co., Ltd., 1-135 Komakado,              Gotemba, Shizuoka 412-8513, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Forerunner Pharma Research Co., Ltd., Komaba Open              Laboratory, The University of Tokyo, 6-1 Komaba 4, Meguro, Tokyo 153-8904,              Japan"},{"name":"Chugai Pharmaceutical Co., Ltd., 1-135 Komakado,              Gotemba, Shizuoka 412-8513, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"121","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1.  Suzuki              M,                Kato              C, and                Kato              A. Therapeutic            antibodies: their mechanisms of action and the pathological findings they induce in            toxicity studies. J Toxicol Pathol.          28: 133\u2013139. 2015.","DOI":"10.1293\/tox.2015-0031"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2.  Leach              MW,                Halpern              WG,                Johnson              CW,                Rojko              JL,                MacLachlan              TK,                Chan              CM,                Galbreath              EJ,                Ndifor              AM,                Blanset              DL,                Polack              E, and                Cavagnaro              JA. Use of            tissue cross-reactivity studies in the development of antibody-based biopharmaceuticals:            history, experience, methodology, and future directions. Toxicol            Pathol. 38: 1138\u20131166.            2010.","DOI":"10.1177\/0192623310382559"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3.  Fukuoka              J,                Dracheva              T,                Shih              JH,                Hewitt              SM,                Fujii              T,                Kishor              A,                Mann              F,                Shilo              K,                Franks              TJ,                Travis              WD, and                Jen              J. Desmoglein 3            as a prognostic factor in lung cancer. Hum Pathol.            38: 276\u2013283. 2007.","DOI":"10.1016\/j.humpath.2006.08.006"},{"key":"4","unstructured":"4.  Chen              YJ,                Chang              JT,                Lee              L,                Wang              HM,                Liao              CT,                Chiu              CC,                Chen              PJ, and                Cheng              AJ. DSG3 is            overexpressed in head neck cancer and is a potential molecular target for inhibition of            oncogenesis. Acta Histochem. 116:            803\u2013809. 2014."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5.  Fang              WK,                Chen              B,                Xu              XE,                Liao              LD,                Wu              ZY,                Wu              JY,                Shen              J,                Xu              LY, and                Li              EM. Altered            expression and localization of desmoglein 3 in esophageal squamous cell            carcinoma. Acta Histochem. 116:            803\u2013809. 2014.","DOI":"10.1016\/j.acthis.2014.01.010"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6.  Shirakata              Y,                Amagai              M,                Hanakawa              Y,                Nishikawa              T, and                Hashimoto              K. Lack of            mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein            1. J Invest Dermatol. 110:            76\u201378. 1998.","DOI":"10.1046\/j.1523-1747.1998.00085.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7.  Kitajima              Y. 150(th)            anniversary series: Desmosomes and autoimmune disease, perspective of dynamic desmosome            remodeling and its impairments in pemphigus. Cell Commun            Adhes. 21: 269\u2013280.            2014.","DOI":"10.3109\/15419061.2014.943397"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8.  Kasperkiewicz              M,                Ellebrecht              CT,                Takahashi              H,                Yamagami              J,                Zillikens              D,                Payne              AS, and                Amagai              M.            Pemphigus. Nat Rev Dis Primers.            3: 17026. 2017.","DOI":"10.1038\/nrdp.2017.26"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9.  Amagai              M, and                Stanley              JR. Desmoglein            as a target in skin disease and beyond. J Invest            Dermatol. 132: 776\u2013784.            2012.","DOI":"10.1038\/jid.2011.390"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10.  Funahashi              SI,                Kawai              S,                Fujii              E,                Taniguchi              K,                Nakano              K,                Ishikawa              S,                Aburatani              H, and                Suzuki              M. Generation            of an anti-desmoglein 3 antibody without pathogenic activity of pemphigus vulgaris for            therapeutic application to squamous cell carcinoma. J            Biochem. 164: 471\u2013481.            2018.","DOI":"10.1093\/jb\/mvy074"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11.  Ishiguro              T,                Sugimoto              M,                Kinoshita              Y,                Miyazaki              Y,                Nakano              K,                Tsunoda              H,                Sugo              I,                Ohizumi              I,                Aburatani              H,                Hamakubo              T,                Kodama              T,                Tsuchiya              M, and                Yamada-Okabe              H.            Anti-glypican 3 antibody as a potential antitumor agent for human liver            cancer. Cancer Res. 68:            9832\u20139838. 2008.","DOI":"10.1158\/0008-5472.CAN-08-1973"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12.  Kawai              S,                Koishihara              Y,                Iida              S,                Ozaki              S,                Matsumoto              T,                Kosaka              M, and                Yamada-Okabe              H. Construction            of a conventional non-radioisotope method to quantify HM1.24 antigens: correlation of            HM1.24 levels and ADCC activity of the humanized antibody against          HM1.24. Leuk Res. 30:            949\u2013956. 2006.","DOI":"10.1016\/j.leukres.2005.11.023"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13.  Kawai              S,                Yoshimura              Y,                Iida              S,                Kinoshita              Y,                Koishihara              Y,                Ozaki              S,                Matsumoto              T,                Kosaka              M, and                Yamada-Okabe              H. Antitumor            activity of humanized monoclonal antibody against HM1.24 antigen in human myeloma            xenograft models. Oncol Rep. 15:            361\u2013367. 2006.","DOI":"10.3892\/or.15.2.361"},{"key":"14","unstructured":"14.  Sato              Y,                Mukai              K,                Watanabe              S,                Goto              M, and                Shimosato              Y. The AMeX            method. A simplified technique of tissue processing and paraffin embedding with improved            preservation of antigens for immunostaining. Am J            Pathol. 125: 431\u2013435.            1986."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15.  Suzuki              M,                Katsuyama              K,                Adachi              K,                Ogawa              Y,                Yorozu              K,                Fujii              E,                Misawa              Y, and                Sugimoto              T. Combination            of fixation using PLP fixative and embedding in paraffin by the AMeX method is useful            for histochemical studies in assessment of immunotoxicity. J            Toxicol Sci. 27: 165\u2013172.            2002.","DOI":"10.2131\/jts.27.165"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16.  Stanley              JR, and                Amagai              M. Pemphigus,            bullous impetigo, and the staphylococcal scalded-skin syndrome.            N Engl J Med. 355:            1800\u20131810. 2006.","DOI":"10.1056\/NEJMra061111"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17.  Westwood              FR. The female            rat reproductive cycle: a practical histological guide to staging.            Toxicol Pathol. 36:            375\u2013384. 2008.","DOI":"10.1177\/0192623308315665"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18.  R\u00f6tzer              V,                Hartlieb              E,                Winkler              J,                Walter              E,                Schlipp              A,                Sardy              M,                Spindler              V, and                Waschke              J. Desmoglein            3-dependent signaling regulates keratinocyte migration and wound          healing. J Invest Dermatol. 136:            301\u2013310. 2016.","DOI":"10.1038\/JID.2015.380"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19.  Merritt              AJ,                Berika              MY,                Zhai              W,                Kirk              SE,                Ji              B,                Hardman              MJ, and                Garrod              DR. Suprabasal            desmoglein 3 expression in the epidermis of transgenic mice results in            hyperproliferation and abnormal differentiation. Mol Cell            Biol. 22: 5846\u20135858.            2002.","DOI":"10.1128\/MCB.22.16.5846-5858.2002"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20.  Elias              PM,                Matsuyoshi              N,                Wu              H,                Lin              C,                Wang              ZH,                Brown              BE, and                Stanley              JR. Desmoglein            isoform distribution affects stratum corneum structure and function.            J Cell Biol. 153:            243\u2013249. 2001.","DOI":"10.1083\/jcb.153.2.243"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21.  Cotreau              MM,                Chennathukuzhi              VM,                Harris              HA,                Han              L,                Dorner              AJ,                Apseloff              G,                Varadarajan              U,                Hatstat              E,                Zakaria              M,                Strahs              AL,                Crabtree              JS,                Winneker              RC, and                Jelinsky              SA. A study of            17beta-estradiol-regulated genes in the vagina of postmenopausal women with vaginal            atrophy. Maturitas. 58:            366\u2013376. 2007.","DOI":"10.1016\/j.maturitas.2007.09.009"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22.  Maynadier              M,                Chambon              M,                Basile              I,                Gleizes              M,                Nirde              P,                Gary-Bobo              M, and                Garcia              M. Estrogens            promote cell-cell adhesion of normal and malignant mammary cells through increased            desmosome formation. Mol Cell Endocrinol.            364: 126\u2013133. 2012.","DOI":"10.1016\/j.mce.2012.08.016"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23.  Suzuki              A,                Enari              M,                Abe              Y,                Ohta              Y, and                Iguchi              T. Effect of            ovariectomy on histological change and protein expression in female mouse reproductive            tracts. In Vivo. 10:            103\u2013110. 1996.","DOI":"10.1016\/0890-6238(95)02055-1"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24.  Farage              MA, and                Maibach              HI. Morphology            and physiological changes of genital skin and mucosa. Curr Probl            Dermatol. 40: 9\u201319.            2011.","DOI":"10.1159\/000321042"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25.  Lagiou              P,                Trichopoulos              D, and                Adami              HO. Chapter 26. Epidemiology          in the identification of cancer causes. In: The Cancer Handbook, Volume 1, 2nd ed. MR          Alison (ed). John Wiley & Sons Ltd., West Sussex. 644\u2013665.          2007.","DOI":"10.1002\/9780470025079.chap19.pub2"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26.  Fujii              E,                Watanabe              K,                Nishihara              K,                Suzuki              M, and                Kato              A. Hazard            characterization of an anti-human tissue factor antibody by combining results of tissue            cross-reactivity studies and distribution of hemorrhagic lesions in monkey toxicity            studies. Regul Toxicol Pharmacol. 90:            289\u2013296. 2017.","DOI":"10.1016\/j.yrtph.2017.09.025"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27.  Kato              A,                Watanabe              T,                Yamazaki              M,                Deki              T, and                Suzuki              M. IL-6R            distribution in normal human and cynomolgus monkey tissues.            Regul Toxicol Pharmacol. 53:            46\u201351. 2009.","DOI":"10.1016\/j.yrtph.2008.10.007"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28.  Furukawa              S,                Nagaike              M, and                Ozaki              K. Databases            for technical aspects of immunohistochemistry. J Toxicol            Pathol. 30: 79\u2013107.            2017.","DOI":"10.1293\/tox.2016-0047"}],"container-title":["Journal of Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tox\/33\/2\/33_2019-0040\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T03:18:42Z","timestamp":1587784722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tox\/33\/2\/33_2019-0040\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1293\/tox.2019-0040","relation":{},"ISSN":["0914-9198","1881-915X"],"issn-type":[{"value":"0914-9198","type":"print"},{"value":"1881-915X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}